Scheinberg DA - Search Results

1

(124)I-huA33 antibody PET of colorectal cancer.

Carrasquillo JA, Pandit-Taskar N, O'Donoghue JA, Humm JL, Zanzonico P, Smith-Jones PM, Divgi CR, Pryma DA, Ruan S, Kemeny NE, Fong Y, Wong D, Jaggi JS, Scheinberg DA, Gonen M, Panageas KS, Ritter G, Jungbluth AA, Old LJ, Larson SM. Carrasquillo JA, et al. Among authors: scheinberg da. J Nucl Med. 2011 Aug;52(8):1173-80. doi: 10.2967/jnumed.110.086165. Epub 2011 Jul 15. J Nucl Med. 2011. PMID: 21764796 Free PMC article. Clinical Trial.

2

A monoclonal antibody for terminal beta-galactose. Use in analysis of glycosphingolipids.

Kalisiak A, Oosterwijk E, Minniti JG, Old LJ, Scheinberg DA. Kalisiak A, et al. Among authors: scheinberg da. Glycoconj J. 1991 Feb;8(1):55-62. doi: 10.1007/BF00731643. Glycoconj J. 1991. PMID: 1726670

3

Monoclonal antibodies against Gal alpha 1-4Gal beta 1-4Glc (Pk, CD77) produced with a synthetic glycoconjugate as immunogen: reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors.

Oosterwijk E, Kalisiak A, Wakka JC, Scheinberg DA, Old LJ. Oosterwijk E, et al. Among authors: scheinberg da. Int J Cancer. 1991 Jul 30;48(6):848-54. doi: 10.1002/ijc.2910480610. Int J Cancer. 1991. PMID: 1860732

4

Neutral glycosphingolipid expression in B-cell neoplasms.

Kalisiak A, Minniti JG, Oosterwijk E, Old LJ, Scheinberg DA. Kalisiak A, et al. Among authors: scheinberg da. Int J Cancer. 1991 Dec 2;49(6):837-45. doi: 10.1002/ijc.2910490607. Int J Cancer. 1991. PMID: 1959988

5

A phase I trial of monoclonal antibody M195 in acute myelogenous leukemia: specific bone marrow targeting and internalization of radionuclide.

Scheinberg DA, Lovett D, Divgi CR, Graham MC, Berman E, Pentlow K, Feirt N, Finn RD, Clarkson BD, Gee TS, et al. Scheinberg DA, et al. J Clin Oncol. 1991 Mar;9(3):478-90. doi: 10.1200/JCO.1991.9.3.478. J Clin Oncol. 1991. PMID: 1999719 Clinical Trial.

6

A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression.

Scheinberg DA, Straus DJ, Yeh SD, Divgi C, Garin-Chesa P, Graham M, Pentlow K, Coit D, Oettgen HF, Old LJ. Scheinberg DA, et al. J Clin Oncol. 1990 May;8(5):792-803. doi: 10.1200/JCO.1990.8.5.792. J Clin Oncol. 1990. PMID: 2332769

7

Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.

Tanimoto M, Scheinberg DA, Cordon-Cardo C, Huie D, Clarkson BD, Old LJ. Tanimoto M, et al. Among authors: scheinberg da. Leukemia. 1989 May;3(5):339-48. Leukemia. 1989. PMID: 2716349

8

Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia.

Scheinberg DA, Tanimoto M, McKenzie S, Strife A, Old LJ, Clarkson BD. Scheinberg DA, et al. Leukemia. 1989 Jun;3(6):440-5. Leukemia. 1989. PMID: 2725060

9

Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.

Jurcic JG, Caron PC, Miller WH Jr, Yao TJ, Maslak P, Finn RD, Larson SM, Warrell RP Jr, Scheinberg DA. Jurcic JG, et al. Among authors: scheinberg da. Leukemia. 1995 Feb;9(2):244-8. Leukemia. 1995. PMID: 7869759

10

Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemia.

Caron PC, Schwartz MA, Co MS, Queen C, Finn RD, Graham MC, Divgi CR, Larson SM, Scheinberg DA. Caron PC, et al. Among authors: scheinberg da. Cancer. 1994 Feb 1;73(3 Suppl):1049-56. doi: 10.1002/1097-0142(19940201)73:3+<1049::aid-cncr2820731344>3.0.co;2-1. Cancer. 1994. PMID: 8306247 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters